NeuroCatch Inc.
9
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
1 terminated/withdrawn out of 9 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Effectiveness of Rehabilitation in Adults Suffering From Persistent Concussion Symptoms
Role: collaborator
NeuroCatch Reference Interval Database
Role: collaborator
Sleep Deprivation Study
Role: lead
NCP 2.0 Repeat Study
Role: lead
Assessing the Impact of the NeuroCatch Platform 2 Stimulus Tone Volume
Role: lead
Assessing Brain Changes Throughout the ABI Wellness Program
Role: lead
Development of a Reference Interval Database With the NeuroCatch™ Platform
Role: lead
Assessing Repeatability of NeuroCatch Platform™ Measurements: An Initial Assessment
Role: lead
Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion
Role: collaborator
All 9 trials loaded